KLOTHO NEUROSCIENCES INC(NASDAQ:KLTO) stock News

KLTO Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Announces Expiration of Letter of Intent

19 days ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

a month ago - By: Klotho Neurosciences, Inc.

CEO van Klotho Neurosciences neemt deel aan inaugurele conferentie en wetenschappelijk seminar

a month ago - By: Klotho Neurosciences, Inc.

Le PDG de Klotho Neurosciences participera à la conférence inaugurale et au séminaire scientifique

a month ago - By: Klotho Neurosciences, Inc.

CEO von Klotho Neurosciences nimmt an Eröffnungskonferenz und wissenschaftlichem Seminar teil

a month ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

a month ago - By: Benzinga - Mentions: NBY PHR IMCC PMN ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

a month ago - By: Benzinga - Mentions: CERO NXTT CPRT BRIA ...

Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

2 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

3 months ago - By: Klotho Neurosciences, Inc.

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

3 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

3 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

3 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

3 months ago - By: Stocktwits

Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy

4 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

4 months ago - By: Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

4 months ago - By: Klotho Neurosciences, Inc.

KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS

4 months ago - By: Klotho Neurosciences, Inc.

KLOTHO NEUROSCIENCES INC (KLTO) Stock News

KLTO Latest News, Press Relases and Analysis

Klotho Neurosciences Announces Expiration of Letter of Intent

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

CEO van Klotho Neurosciences neemt deel aan inaugurele conferentie en wetenschappelijk seminar

Le PDG de Klotho Neurosciences participera à la conférence inaugurale et au séminaire scientifique

CEO von Klotho Neurosciences nimmt an Eröffnungskonferenz und wissenschaftlichem Seminar teil

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS

KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT